MedTrace Logo

Effect of NAC on Sleep Apnea

NCT00592618 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2008-01-14

No results posted yet for this study

Summary

Sleep studies in ESRD patients have identified increased prevalence of Sleep Apnea. Based on current knowledge, treatment aimed at reducing oxidative stress might improve Sleep Apnea in HD patients. The aim of our study is to investigate the effect of N-acetylsysteine on Sleep Apnea in HD patients.

Conditions

Interventions

DRUG

Oral N-Acetylcysteine 1200 mg x 2/day for 4 weeks

Sponsors & Collaborators

  • Assaf-Harofeh Medical Center

    lead OTHER_GOV

Principal Investigators

  • Leonid S Feldman, MD · Assaf Harofeh MC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00592618 on ClinicalTrials.gov